李靖欣 - Department of Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention

基本信息

浏览量：19

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 172 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine Versus Live Attenuated Vaccine

Jiaqi Wang,Pengfei Jin,Hui Jin,Qiang Wang,Fengcai Zhu,Jingxin Li

VACCINESno. 8 (2024)

引用0浏览0WOS引用

Comparison of 1 Versus 2 Doses of Quadrivalent Influenza Vaccine in 3-8-year-old Children with Different Immunological States - Jiangsu Province, China, 2021

Qian Liu,Pengfei Jin,Jingxin Li,Xiaoqin Chen, Chenhao Wang,Qingbin Lu,Wei Jiang, Shixuan Zhang,Lairun Jin, Hongxin Pan,Xue Guo,Fengcai Zhu

CHINA CDC WEEKLYno. 19 (2024)

引用0浏览0WOS引用

Immunological aspects of emerging and re-emerging zoonoses

Wei Wang,Jingxin Li,Yuejin Liang, Wenping Gong

FRONTIERS IN IMMUNOLOGY (2024): 1392382-1392382

引用0浏览0WOS引用

Safety, Immunogenicity, and Efficacy of a Modified COVID-19 Mrna Vaccine, SW-BIC-213, in Healthy People Aged 18 Years and Above: a Phase 3 Double-Blinded, Randomized, Parallel Controlled Clinical Trial in Lao PDR (Laos)

Yi Fang,Jing-Xin Li, Davone Duangdany,Yang Li,Xi-Lin Guo,Chanthala Phamisith, Bo Yu,Ming-Yun Shen, Bin Luo,Yu-Zhu Wang, Si-Jun Liu,Fan-Fan Zhao,Cong-Cong Xu, Xu-Hui Qiu, Rong Yan,Yu-Zhou Gui,Rong-Juan Pei, Jie Wang,Haifa Shen,Wu-Xiang Guan,Hang-Wen Li,Mayfong Mayxay

ECLINICALMEDICINE（2024）

引用0浏览0WOS引用

Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine As the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial

Yawen Zhu,Rong Tang,Xiaolong Li,Xiaoqin Chen, Xue Wang,Ying Wang,Ruijie Wang,Fengcai Zhu,Jingxin Li

VACCINESno. 3 (2024)

引用0浏览0WOS引用

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

Chris Wynne, Abundio Balgos,Jingxin Li, Paul Hamilton,Louie Tirador,Anjuli May Jaen,Chen Mo, Zijing Yue, Ying Ma, Qingshuang Wang, Rendu Wen, Zheng Yao,Jiaping Yu,Wenrong Yao, Jianhui Zhang,Hui Zheng,Kunxue Hong,Fengcai Zhu, Yong Liu

INFECTIOUS DISEASES AND THERAPY（2024）

引用0浏览0WOS引用

Even a Small Stride Can Have a Significant Impact: Enhancing the Effectiveness of Influenza Vaccines

Wang Weixiao,Li Jingxin

Infectious Diseases & Immunityno. 2 (2024): 56-57

引用0浏览0引用

Relative Effectiveness of a Heterologous Booster Dose with Adenovirus Type 5 Vectored COVID-19 Vaccine Versus Three Doses of Inactivated COVID-19 Vaccine in Adults During a Nationwide Outbreak of Omicron Predominance, in China: a Retrospective, Individually Matched Cohort-Control Study

Siyue Jia,Zundong Yin,Hongxing Pan,Fuzhen Wang,Xiaoqiang Liu, Qing Wang,Li Zhang, Jihai Tang, Hao Yang,Jiangbo Du, Zhiguo Wang,Pengfei Jin,Zhihang Peng,Rong Tang,Guodong Kang,Xuewen Wang, Simin Li, Weixiao Wang,Jingxin Li,Hongbing Shen,Fengcai Zhu

EMERGING MICROBES & INFECTIONS（2024）

引用0浏览0WOS引用

Immunogenicity and Safety of Boosting with a Recombinant Two-Component SARS-CoV-2 Vaccine: Two Randomized, Parallel-Controlled, Phase 2 Studies

Abundio Balgos,Suad Hannawi, Wen-Li Chen,Alaa Abuquta,Linda Safeldin,Aala Hassan,Ahmad Alamadi,Louie Tirador,Anjuli May Jaen,Ralph Elvi Villalobos,Chen Mo, Zi-Jing Yue, Ying Ma, Qing-Shuang Wang, Ren-Du Wen, Zheng Yao,Jia-Ping Yu,Wen-Rong Yao, Jian-Hui Zhang,Kun-Xue Hong, Yong Liu,Jing-Xin Li

EXPERT REVIEW OF VACCINESno. 1 (2024): 419-431

引用0浏览0WOS引用

Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial

Yan-Fei Wu,Ming-Wei Wei,Rui-Jie Wang,Xi-Ling Guo,Hong-Xing Pan, Ya-Chun Gao, Xiao-Long Li, Xue Wang, Xiao-Min Ma,Peng Wan, Li Zhou,Ya-Wen Zhu,Jing-Xin Li,Feng-Cai Zhu

Expert review of vaccinesno. 1 (2023): 662-670

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

JingXin Li(李靖欣)

论文共 172 篇作者统计合作学者相似作者